New Delhi: The recent amendment brought to the compensation guidelines in carrying out clinical trials in the country has cleared "major hurdles" for testing of new drugs, especially for those diseases for which cure is not
Washington: American pharma companies and their advocacy groups on Friday rued at the alleged restrictive India policies on clinical research, saying such policies are harming the companies."Clinical research has become a highly politicised topic in
Top News
Latest News
